Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review)
The article analyzes data from the world literature for the period from 2005 to 2020 on the relationship between the variability of immunohistochemical expression of estrogen and progesterone receptors, HER2/neu protein and the index of proliferative activity in invasive breast cancer with the cours...
Saved in:
Main Authors: | Yu. S. Krumin (Author), V. A. Khaylenko (Author), N. A. Kozlov (Author), G. Yu. Cheremis (Author), A. V. Petrovskyy (Author), D. V. Khaylenko (Author), E. V. Artamonova (Author), E. I. Kovalenko (Author) |
---|---|
Format: | Book |
Published: |
ABV-press,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Breast conserving surgery in the treatment of breast cancer stage III
by: D. V. Khaylenko, et al.
Published: (2016) -
Molecular genetic markers of breast cancer
by: K. A. Grishina, et al.
Published: (2016) -
Role of microRNAs in breast cancer development and their potential as biomarkers
by: K. A. Grishina, et al.
Published: (2018) -
Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019) -
Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study
by: L. A. Tashireva, et al.
Published: (2022)